MUVON THERAPEUTICS
Muvon Therapeutics platform helps women with urinary incontinence and treats diseases based on skeletal muscle degradation, supporting them in their commitment to living a healthy life. The company's mode of contact is by mail, phone, and physical address.
MUVON THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science
Founded:
2020-01-01
Address:
Zürich, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.muvon-therapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+41 449 231 188
Email Addresses:
[email protected]
Total Funding:
0
Investors List
Lichtsteiner Foundation
Lichtsteiner Foundation investment in Series A - MUVON Therapeutics
Wyss Zurich
Wyss Zurich investment in Series A - MUVON Therapeutics
University of Zurich
University of Zurich investment in Series A - MUVON Therapeutics
Horizon 2020
Horizon 2020 investment in Series A - MUVON Therapeutics
Official Site Inspections
http://www.muvon-therapeutics.com
Unable to get host informations!!!
More informations about "MUVON Therapeutics"
Muvon Therapeutics | muscle tissue regeneration | Switzerland
MUVON Therapeutics is a clinical stage Life Science spin-off from the University of Zurich developing a therapeutic platform for the regeneration of skeletal muscle tissue based on …See details»
ABOUT US - Muvon Therapeutics | Switzerland
MUVON Therapeutics is a clinical stage Life Science Spin-off from the University of Zurich developing a novel therapy platform for the regeneration of skeletal muscle tissue based on …See details»
MUVON Therapeutics - Crunchbase Company Profile
Muvon Therapeutics is a biotech company developing autologous cell therapies to restore skeletal muscle. View contacts for MUVON Therapeutics to access …See details»
Muvon Therapeutics Announces First Patient Enrolled in Phase II ...
Oct 27, 2022 · Zurich, Switzerland, October 27, 2022 – Muvon Therapeutics AG, an innovative clinical-stage biotechnology company, today announced that the first patient with Stress …See details»
MUVON Therapeutics AG - LinkedIn
MUVON Therapeutics is a clinical stage Life Science spin-off from the University of Zurich developing a therapeutic platform for the regeneration of skeletal muscle tissue based on autologous...See details»
MUVON Therapeutics AG - Swiss Biotech
MUVON Therapeutics is a Swiss clinical stage biotech company with the goal of revolutionizing the treatment of various diseases caused by muscle damage or degradation through the use of the patients' own cells. Our initial area of focus …See details»
MUVON Therapeutics - VentureRadar
Website: https://www.muvon-therapeutics.com. Develops autologous cell therapy solutions aimed at regenerating skeletal muscle tissue, promoting recovery and improving muscle function. …See details»
MUVON Therapeutics | Innovation Hub - UZH
After a decade of interdisciplinary research at the UZH, the spin-off MUVON Therapeutics was founded. The first objective of the company is to market the regenerative treatment of stress …See details»
MUVON Therapeutics - Funding, Financials, Valuation & Investors
Muvon Therapeutics is a biotech company developing autologous cell therapies to restore skeletal muscle.See details»
Deana Mohr-Haralampieva – CEO & Co-Founder, MUVON …
Nov 5, 2024 · What is the core technology behind MUVON Therapeutics, and why did you decide to focus on Female Stress Urinary Incontinence (SUI) as your primary area of treatment? …See details»
MUVON - Wyss Zurich
MUVON is developing a low-risk, minimally invasive treatment that uses the patient’s own muscle precursor cells (MPC) to regenerate the damaged sphincter muscle, thus potentially providing a cure for SUI.See details»
MUVON Therapeutics AG - top100startup.ch
Mar 31, 2021 · We reverse age- or damage-related disability for functional skeletal muscle regeneration. Our cell-based regenerative platform technology allows for successful muscle …See details»
The Beginning of the MUVON Story - Muvon Therapeutics
Dec 21, 2020 · The technology behind MUVON was developed over the past decade at the University of Zurich and in recent years has been funded by the EU under the Horizon 2020 …See details»
Muvon Therapeutics Announces Successful Phase I Clinical Study …
09-09-2022 – MUVON Therapeutics AG presented today at the International Continence Society (ICS) Annual Meeting in Vienna, the study findings showing the successful completion of …See details»
Treating stress urinary incontinence by tissue engineering
Sep 16, 2024 · MUVON Therapeutics has developed a tissue-engineered advanced therapy medicinal product for the treatment of SUI, based on autologous cells, which is being tested in …See details»
Deana Mohr-Haralampieva - MUVON Therapeutics | Tissue …
Jul 13, 2023 · Deana Mohr-Haralampieva is the CEO & co-founder at MUVON Therapeutics, a groundbreaking startup developing a therapeutic platform for the regeneration of skeletal …See details»
Meet MUVON Therapeutics co-founder Deana Mohr and discover …
Oct 8, 2021 · Deana Mohr-Haralampieva co-founded MUVON Therapeutics, a Venture Leader Medtech that optimizes autologous cell therapy to regenerate skeletal muscle tissue. …See details»
No stress: regaining bladder control through personalised cell …
MUVON Therapeutics has developed a patent-protected, GMP-compliant method for isolating and expanding muscle precursor cells that are injected into patients to promote regeneration of …See details»
MUVON ranked as a top 3 Biotech and overall 18th in 2024s TOP …
MUVON is honored to be recognized for the second year in a row by the Top100 Swiss Startup community as one of the top 3 biotech startups in Switzerland. This recognition reflects the …See details»
No stress: regaining bladder control through personalised cell
MUVON Therapeutics has developed a patent-protected, GMP-compliant method for isolating and expanding muscle precursor cells that are injected into patients to promote regeneration of …See details»